압타머 시장 규모, 점유율, 동향 분석 보고서 : 종류별, 용도별, 지역별 및 부문별 예측(2026-2033년)

Aptamers Market Summary

The global aptamers market size was valued at USD 1.4 billion in 2025 and is projected to grow from USD 1.6 billion in 2026 to reach USD 5.3 billion by 2033, at a CAGR of 18.3% from 2026 to 2033. North America dominated the global market with the largest revenue share of 43.6% in 2025. The global aptamers market is witnessing significant growth driven by increasing demand for targeted therapeutics, precision medicine, and advanced molecular diagnostics.

In addition, advancements in SELEX technologies, AI-enabled aptamer discovery platforms, and high-throughput screening methods are improving the efficiency, specificity, and scalability of aptamer development, thereby accelerating their adoption across pharmaceutical, biotechnology, and clinical research applications.

Global Aptamers Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global aptamers market report based on type, application, and region:

• Type Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Nucleic Acid Aptamer
• Peptide Aptamer
• Application Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• Diagnostics
• Therapeutics Development
• Research and Development
• Others
• Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Type
  • 1.2.2. Application
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Impact Analysis
    • 3.3.1.1. Advancements in SELEX and high-throughput screening technologies
    • 3.3.1.2. Rising demand for targeted therapeutics and precision medicine
    • 3.3.1.3. Increasing adoption of aptamers in diagnostics and biosensor applications
  • 3.3.2. Market Restraint Impact Analysis
    • 3.3.2.1. High cost associated with aptamer development and commercialization
    • 3.3.2.2. Limited number of approved aptamer-based therapeutics
  • 3.3.3. Market Challenges Analysis
  • 3.3.4. Market Opportunity Analysis
• 3.4. Case Study Insights
• 3.5. Business Environment Analysis
  • 3.5.1. PESTLE Analysis
  • 3.5.2. PORTER'S Five Forces Analysis

Chapter 4. Aptamers Market: Type Business Analysis

• 4.1. Type Market Share, 2025 & 2033
• 4.2. Type Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2021 to 2033 (USD Million/Billion)
• 4.4. Nucleic Acid Aptamer
  • 4.4.1. Nucleic Acid Aptamer Market, 2021-2033 (USD Million/Billion)
• 4.5. Peptide Aptamer
  • 4.5.1. Peptide Aptamer Market, 2021-2033 (USD Million/Billion)

Chapter 5. Aptamers Market: Application Business Analysis

• 5.1. Application Market Share, 2025 & 2033
• 5.2. Application Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million/Billion)
• 5.4. Diagnostics
  • 5.4.1. Diagnostics Market, 2021-2033 (USD Million/Billion)
• 5.5. Therapeutics Development
  • 5.5.1. Therapeutics Market, 2021-2033 (USD Million/Billion)
• 5.6. Research and Development
  • 5.6.1. Research and Development Market, 2021-2033 (USD Million/Billion)
• 5.7. Others
  • 5.7.1. Other Applications Market, 2021-2033 (USD Million/Billion)

Chapter 6. Aptamers Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2025 & 2033
• 6.2. Regional Market Dashboard
• 6.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
• 6.4. North America
  • 6.4.1. North America Aptamers Market Estimates And Forecasts, By Country, 2021 - 2033 (USD Million/Billion)
  • 6.4.2. U.S.
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Regulatory Framework
    • 6.4.2.3. Competitive Insights
    • 6.4.2.4. U.S. Aptamers Market Estimates And Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.4.3. Canada
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Regulatory Framework
    • 6.4.3.3. Competitive Insights
    • 6.4.3.4. Canada Aptamers Market Estimates And Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.4.4. Mexico
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Regulatory Framework
    • 6.4.4.3. Competitive Insights
    • 6.4.4.4. Mexico Aptamers Market Estimates And Forecasts, 2021 - 2033 (USD Million/Billion)
• 6.5. Europe
  • 6.5.1. Europe Aptamers Market Estimates And Forecasts, By Country, 2021 - 2033 (USD Million/Billion)
  • 6.5.2. UK
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Regulatory Framework
    • 6.5.2.3. Competitive Insights
    • 6.5.2.4. UK Aptamers Market Estimates And Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.5.3. Germany
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Regulatory Framework
    • 6.5.3.3. Competitive Insights
    • 6.5.3.4. Germany Aptamers Market Estimates And Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.5.4. France
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Regulatory Framework
    • 6.5.4.3. Competitive Insights
    • 6.5.4.4. France Aptamers Market Estimates And Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.5.5. Italy
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Regulatory Framework
    • 6.5.5.3. Competitive Insights
    • 6.5.5.4. Italy Aptamers Market Estimates And Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.5.6. Spain
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Regulatory Framework
    • 6.5.6.3. Competitive Insights
    • 6.5.6.4. Spain Aptamers Market Estimates And Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.5.7. Norway
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Regulatory Framework
    • 6.5.7.3. Competitive Insights
    • 6.5.7.4. Norway Aptamers Market Estimates And Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.5.8. Denmark
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Regulatory Framework
    • 6.5.8.3. Competitive Insights
    • 6.5.8.4. Denmark Aptamers Market Estimates And Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.5.9. Sweden
    • 6.5.9.1. Key Country Dynamics
    • 6.5.9.2. Regulatory Framework
    • 6.5.9.3. Competitive Insights
    • 6.5.9.4. Sweden Aptamers Market Estimates And Forecasts, 2021 - 2033 (USD Million/Billion)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific Aptamers Market Estimates And Forecasts, By Country, 2021 - 2033 (USD Million/Billion)
  • 6.6.2. Japan
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Regulatory Framework
    • 6.6.2.3. Competitive Insights
    • 6.6.2.4. Japan Aptamers Market Estimates And Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.6.3. China
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Regulatory Framework
    • 6.6.3.3. Competitive Insights
    • 6.6.3.4. China Aptamers Market Estimates And Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.6.4. India
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Regulatory Framework
    • 6.6.4.3. Competitive Insights
    • 6.6.4.4. India Aptamers Market Estimates And Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.6.5. South Korea
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Regulatory Framework
    • 6.6.5.3. Competitive Insights
    • 6.6.5.4. South Korea Aptamers Market Estimates And Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.6.6. Australia
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Regulatory Framework
    • 6.6.6.3. Competitive Insights
    • 6.6.6.4. Australia Aptamers Market Estimates And Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.6.7. Thailand
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Regulatory Framework
    • 6.6.7.3. Competitive Insights
    • 6.6.7.4. Thailand Aptamers Market Estimates And Forecasts, 2021 - 2033 (USD Million/Billion)
• 6.7. Latin America
  • 6.7.1. Latin America Aptamers Market Estimates And Forecasts, By Country, 2021 - 2033 (USD Million/Billion)
  • 6.7.2. Brazil
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Regulatory Framework
    • 6.7.2.3. Competitive Insights
    • 6.7.2.4. Brazil Aptamers Market Estimates And Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Regulatory Framework
    • 6.7.3.3. Competitive Insights
    • 6.7.3.4. Argentina Aptamers Market Estimates And Forecasts, 2021 - 2033 (USD Million/Billion)
• 6.8. MEA
  • 6.8.1. MEA Aptamers Market Estimates And Forecasts, By Country, 2021 - 2033 (USD Million/Billion)
  • 6.8.2. South Africa
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Regulatory Framework
    • 6.8.2.3. Competitive Insights
    • 6.8.2.4. South Africa Aptamers Market Estimates And Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Regulatory Framework
    • 6.8.3.3. Competitive Insights
    • 6.8.3.4. Saudi Arabia Aptamers Market Estimates And Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.8.4. UAE
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Regulatory Framework
    • 6.8.4.3. Competitive Insights
    • 6.8.4.4. UAE Aptamers Market Estimates And Forecasts, 2021 - 2033 (USD Million/Billion)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Regulatory Framework
    • 6.8.5.3. Competitive Insights
    • 6.8.5.4. Kuwait Aptamers Market Estimates And Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 7. Competitive Landscape

• 7.1. Company Categorization
• 7.2. Company Market Position Analysis, 2025
• 7.3. Strategy Mapping
• 7.4. Company Profiles/Listing
  • 7.4.1. SomaLogic
    • 7.4.1.1. Overview
    • 7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Strategic Initiatives
  • 7.4.2. Aptamer Group
    • 7.4.2.1. Overview
    • 7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Strategic Initiatives
  • 7.4.3. Aptadel Therapeutics
    • 7.4.3.1. Overview
    • 7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Strategic Initiatives
  • 7.4.4. Base Pair Biotechnologies
    • 7.4.4.1. Overview
    • 7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Strategic Initiatives
  • 7.4.5. Noxxon Pharma
    • 7.4.5.1. Overview
    • 7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Strategic Initiatives
  • 7.4.6. Aptagen, LLC
    • 7.4.6.1. Overview
    • 7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Strategic Initiatives
  • 7.4.7. Vivonics Inc.
    • 7.4.7.1. Overview
    • 7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Strategic Initiatives
  • 7.4.8. TriLink Biotechnologies
    • 7.4.8.1. Overview
    • 7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Strategic Initiatives
  • 7.4.9. Altermune LLC
    • 7.4.9.1. Overview
    • 7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.4.9.3. Product Benchmarking
    • 7.4.9.4. Strategic Initiatives
  • 7.4.10. AM Biotechnologies
    • 7.4.10.1. Overview
    • 7.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.4.10.3. Product Benchmarking
    • 7.4.10.4. Strategic Initiatives